Clinical Experience Presented at Boswick Symposium Shows Rapid Wound Transformation, Enhanced Healing, and Strong Antimicrobial Performance Across Multiple Wound Types WESTMINSTER, CALIFORNIA / ACCESS Newswire / February 18, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator, today announced that clinical experience with ViaCLYR™, Clyra Medical Technologies' advanced wound irrigation solution powered by its proprietary Clyrasept™ technology, was pres

Initial Distribution Launch Marks Transition to Revenue-Generating Operations WESTMINSTER, CALIFORNIA / ACCESS Newswire / February 9, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator, announced today that its subsidiary, Clyra Medical Technologies, Inc., has received its first commercial stocking order from Advanced Solution, LLC for ViaCLYR™, Clyra's FDA-cleared wound irrigation solution. The order marks the start of commercial distribution and r

WESTMINSTER, CALIFORNIA / ACCESS Newswire / January 27, 2026 / BioLargo, Inc. (OTCQX:BLGO) today announced that its patented Aqueous Electrostatic Concentrator (AEC) PFAS treatment system has been installed at the Lake Stockholm municipal water facility in New Jersey. BioLargo CEO Dennis Calvert commented, "The Lake Stockholm installation marks an important milestone for BioLargo as its AEC technology transitions into real-life municipal use. Once the facility goes through

WESTMINSTER, CALIFORNIA / ACCESS Newswire / December 29, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator focused on sustainable water and environmental solutions, announced that it had delivered an open letter to its stockholders as follows: Dear Stockholders, As the world enters what may be one of the largest infrastructure and technology investment cycles in history, BioLargo, Inc. (OTCQX: BLGO), a developer of innovative technologies addressing environmental, en

Lake Stockholm, NJ AEC System Delivered and Preparing to Go Live WESTMINSTER, CALIFORNIA / ACCESS Newswire / December 3, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator focused on sustainable water and environmental solutions, announced that its subsidiary, BioLargo Equipment Solutions & Technologies, Inc. , has been prominently featured in Chemical Engineering magazine for its advances in electrostatic PFAS ("forever chemicals") treatment technology. The article,

Westminster, California--(Newsfile Corp. - November 21, 2025) - BioLargo, Inc. (OTCQX: BLGO), a company that creates and commercializes sustainable technologies to solve challenging environmental and cleantech problems, today announced it will be presenting at Noble Capital Markets' 21 st Annual Emerging Growth Equity Conference at Florida Atlantic University, College of Business Executive Education in Boca Raton, FL on December 3 rd , 2025 at 10:30 AM Eastern Time. BioLarg

WESTMINSTER, CA / ACCESS Newswire / November 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Friday, November 14 th , 2025, at 1:30 pm Pacific / 4:30 pm Eastern. The event, which will be open to the public, will be held to review the company's financial results for the three months ending September 30 th , 2025, discuss recent

Distribution Agreement Brings Innovative Copper-Iodine Complex Technology to Wound Care Market WESTMINSTER, CALIFORNIA / ACCESS Newswire / November 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that creates and commercializes sustainable technologies, announced today its subsidiary Clyra Medical Technologies, Inc., had signed an exclusive stocking distribution agreement with Advanced Solution, LLC. This alliance will leverage Advanced Solution's national netw

Wednesday, 12 November 2025 08:00 AM Nine-count complaint alleges fraud, false advertising, breach of contract, and patent infringement WESTMINSTER, CA / ACCESS Newswire / November 12, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that develops and commercializes sustainable technologies, announced today that it has filed a lawsuit in the U.S. District Court for the Central District of California to protect its patented CupriDyne odor control technology and its

WESTMINSTER, CA / ACCESS Newswire / November 3, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that develops and commercializes sustainable technologies, today announced a breakthrough upgrade to its patented Aqueous Electrostatic Concentrator (AEC) system-cutting the AEC's energy use by more than 90% in large-scale PFAS treatment for drinking water as compared with the prior generations of the AEC. These savings are on top of data reported in May 2025 that an AEC

Cellinity battery cell technology, BioLargo's role in the global AI infrastructure investment cycle, and a general corporate update are featured in the presentation. WESTMINSTER, CA, CA / ACCESS Newswire / October 21, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that creates and commercializes sustainable technologies, today announced that its CEO presented at the LD Micro Main Event XIX, held at the Hotel del Coronado in San Diego, California, on Monday, Octobe

WESTMINSTER, CA, CA / ACCESS Newswire / October 14, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that creates and commercializes sustainable technologies is excited to invite professionals, innovators, and sustainability advocates to the 16th Annual Energy Event, hosted by Sustain SoCal. Join us on Thursday, October 16, 2025, from 9:00 AM to 7:00 PM at The Cove at UCI Beall Applied Innovation in Irvine, CA. This premier conference, themed "Energy in Perspective

Cellinity is a breakthrough battery storage solution for AI infrastructure that eliminates the need for rare earth elements WESTMINSTER, CA, CA / ACCESS Newswire / October 14, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that develops and commercializes sustainable technologies, today announced that its management team will present at the LD Micro Main Event XIX at the Hotel del Coronado in San Diego, California, on Monday, October 20, at 2:00 p.m. Pacific Ti

Initial Commercialization Targeting $732 Million Wound Care Market is Expected in Late 2025 or Early 2026 WESTMINSTER, CALIFORNIA / ACCESS Newswire / October 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that creates and commercializes sustainable technologies, today announced that its subsidiary Clyra Medical Technologies has achieved noteworthy progress across product development, commercialization, and clinical programs, advancing toward multiple near-ter

WESTMINSTER, CA, CA / ACCESS Newswire / October 7, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that creates and...

WESTMINSTER, CALIFORNIA / ACCESS Newswire / September 29, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that creates and...

WESTMINSTER, CALIFORNIA / ACCESS Newswire / September 26, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that creates and...

Pooph owes BioLargo $3.8 million WESTMINSTER, CA / ACCESS Newswire / September 25, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech...

Significantly Advances Energy Technologies and Clyra Medical Technologies WESTMINSTER, CA / ACCESS Newswire / August 13, 2025 /...

WESTMINSTER, CA / ACCESS Newswire / August 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and...